Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2023

14 Dec 2023
Shareholder Update
22 Nov 2023
Results of Annual General Meeting
22 Nov 2023
Presentation at Annual General Meeting
27 Oct 2023
Report on Activities for the Quarter Ended 30 September 2023
27 Oct 2023
Quarterly Report 30 September 2023
26 Oct 2023
Application for Quotation of Securities
24 Oct 2023
Presentation to Investors
20 Oct 2023
Annual Report and Notice of AGM
26 Sep 2023
Shareholder Update
11 Sep 2023
Response to ASX Price Query
25 Aug 2023
Corporate Governance Statement 2023
25 Aug 2023
Appendix 4G
25 Aug 2023
Year End Accounts and Preliminary Final Report
16 Aug 2023
Completion of Phase 2 COVID Clinical Trial
28 Jul 2023
Report on Activities for the Quarter Ended 30 June 2023
28 Jul 2023
Quarterly Report 30 June 2023
12 May 2023
Second Site Approved for Phase 2 COVID-19 Trial
4 May 2023
Commencement of Phase 2 COVID-19 Clinical Trial
27 Apr 2023
Report on Activities for the Quarter Ended 31 March 2023
27 Apr 2023
Quarterly Report 31 March 2023
9 Mar 2023
Completion of Phase 2 HIV-1 Clinical Trials
21 Feb 2023
Presentation of BIT225 COVID-19 Data at International Conference
17 Feb 2023
Half-year Report 31 December 2022
7 Feb 2023
Notice of Cessation of Securities
31 Jan 2023
Report on Activities for the Quarter Ended 31 December 2022
31 Jan 2023
Quarterly Report 31 December 2022

<<
2025
2024
2023
2022

2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 January 2025 Legal Notices and Privacy